Science Daily - Heart Disease
OCTOBER 31, 2024
New research has found inflammatory markers in the blood of long COVID patients which could explain why many experience ongoing cardiovascular issues.
HCPLive
OCTOBER 31, 2024
In this first of this 5-part series, Lerma and Lala-Trindade discuss the interplay between chronic kidney disease and cardiovascular disease.
Medical Xpress - Cardiology
OCTOBER 31, 2024
University of Queensland-led research has found inflammatory markers in the blood of long COVID patients which could explain why many experience ongoing cardiovascular issues.
HCPLive
OCTOBER 31, 2024
Mohammad Abuassi, MD, explains how classifying IBS based on triggers can aid the development of effective, personalized approaches to management.
Med Page Today
OCTOBER 31, 2024
(MedPage Today) -- Intraosseous vascular access for the administration of epinephrine during out-of-hospital cardiac arrest wasn't better than going for the veins first, two separate randomized trials showed. In the PARAMEDIC-3 trial conducted.
Medical Xpress - Cardiology
OCTOBER 31, 2024
There is no difference in the effectiveness of the two most commonly used methods for administering medication during out-of-hospital cardiac arrest.
HCPLive
OCTOBER 31, 2024
Yee discussed research she is conducting into gFSGS and nephrotic syndrome, presented at ASN Kidney Week.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
OCTOBER 31, 2024
Sexual trauma and genetic risk independently and together raise mental illness risk, a new study found.
Medical Xpress - Cardiology
OCTOBER 31, 2024
Each year, an estimated 15 million people around the globe experience stroke, according to the World Health Organization, with one-third resulting in death. That's why immediate stroke treatment is crucial.
HCPLive
OCTOBER 31, 2024
In the final part of this 5-part series, Lala-Trindade discusses the findings of the FINEARTS-HF trial and how it might inform use of finerenone.
Medical Xpress - Cardiology
OCTOBER 31, 2024
Introducing tougher restrictions on sodium levels for packaged food could prevent thousands of deaths and save billions of dollars in health spending in Australia alone, a new study shows.
Science Daily - Stroke
OCTOBER 31, 2024
A study of more than 13 million hours of data, collected from light sensors worn by 89,000 people, has found exposure to bright nights and dark days is associated with an increased risk of death.
HCPLive
OCTOBER 31, 2024
These data suggest brodalumab’s safety profile is consistent with findings from long-term clinical trials, with no new occurrences of suicide and a low rate of fungal infection.
Becker's Hospital Review - Cardiology
OCTOBER 31, 2024
Traditionally, patients with a failing heart valve were advised to return in six to 12 months, as physicians generally took a "wait and see" approach, but a new study suggests patients may benefit more if their valves are replaced immediately through a minimally invasive procedure.
HCPLive
OCTOBER 31, 2024
Panaccione provides insight into the efficacy of risankizumab maintenance therapy by induction outcomes and explains which dose may be more effective.
American College of Cardiology
OCTOBER 31, 2024
Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Early management of this condition is typically dictated by the degree of pulmonary stenosis (PS) and resulting oxygen saturations.
HCPLive
OCTOBER 31, 2024
T-VASI and F-VASI are validated, responsive tools for assessing vitiligo severity and re-pigmentation, with meaningful change thresholds established.
Cardiovascular Diabetology
OCTOBER 31, 2024
The association between metabolic dysfunction-associated steatotic liver disease (MASLD) and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM) is unclear. This study aimed to investigate.
Frontiers in Cardiovascular Medicine
OCTOBER 31, 2024
BackgroundAccurately assessing the postoperative mortality and rehospitalization for heart failure risks in patients undergoing mitral valve repair surgery is of significant importance for individualized medical strategies.ObjectiveWe sought to develop and validate a risk assessment system for the prediction of mortality and rehospitalization for heart failure.MethodsPersonalized risk prediction system of mortality and rehospitalization for heart failure was developed.
Open Heart
OCTOBER 31, 2024
Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Serum uric acid (SUA), a product of purine metabolism, has been implicated in HF progression. However, the association between hyperuricaemia and the short-term readmission and mortality in patients with HF remains controversial. Methods In this retrospective cohort study, we analysed data from a HF database specific to the Chinese population.
Med Page Today
OCTOBER 31, 2024
(MedPage Today) -- The Evoque transcatheter tricuspid valve replacement (TTVR) system continued to show significant benefits 1 year after implant, according to an update from the TRISCEND II trial. Among study participants with symptomatic, severe.
MIBHS
OCTOBER 31, 2024
The heart is one of the most critical organs in the human body, responsible for pumping blood throughout the system to supply oxygen and nutrients. While a healthy heart maintains its size relative to the individual, conditions can cause it to enlarge—a condition known as cardiomegaly or an enlarged heart. An enlarged heart is not a disease but rather a symptom of an underlying issue.
Frontiers in Cardiovascular Medicine
OCTOBER 31, 2024
BackgroundThere have been few instances of symptomatic bradycardia-arrhythmia in the context of area postrema syndrome (APS), and some of them have been implanted permanent pacemakers. Cardioneuroablation (CNA) has emerged as a viable therapy for the treatment of syncope induced by neutrally mediated bradycardia or atrioventricular block.MethodsWe report a young patient with recurrent cardiac asystole and syncope following persistent hiccups caused by neuromyelitis optica spectrum disorder (NMOS
HCPLive
OCTOBER 31, 2024
In part 3 of this 5-part series, Lerma discusses recent updates in the management of chronic kidney disease in people with type 2 diabetes.
Frontiers in Cardiovascular Medicine
OCTOBER 31, 2024
BackgroundThe complex relationship between insulin-like growth factor 1 (IGF-1) levels and heart failure (HF) is not fully understood, particularly across different populations and conditions. This meta-analysis aims to elucidate the dual perspectives of IGF-1 levels in the general population, HF patients, and individuals with treatment-naïve acromegaly, highlighting IGF-1 as a biomarker and potential therapeutic target in HF management.MethodsStudies were searched across multiple electronic dat
Becker's Hospital Review - Cardiology
OCTOBER 31, 2024
"CMS has proposed coverage of implantable pulmonary artery pressure sensors for heart failure management. Learn about the criteria and public comment period.
HCPLive
OCTOBER 31, 2024
This interview from Fall Clinical featured a discussion of new findings on upadacitinib (Rinvoq) for patients with atopic dermatitis.
Medical Xpress - Cardiology
OCTOBER 31, 2024
Ochsner Health physicians Dr. Richard Zweifler and Dr. Joseph Tarsia are co-authors on a post hoc analysis carried out in the ARCADIA randomized clinical trial, comparing the effectiveness of apixaban versus aspirin in preventing adverse clinical outcomes in patients with a history of cancer and cryptogenic stroke. The research found no significant difference in the risk of major ischemic and hemorrhagic events between those taking apixaban and aspirin.
American College of Cardiology
OCTOBER 31, 2024
What are the contemporary outcomes and predictors of adverse events following endovascular treatment of acute limb ischemia (ALI) in a broad, nationwide, multicenter peripheral vascular registry?
HCPLive
OCTOBER 31, 2024
In part 4 of this 5-part series, discussants explore the influence of recent guidelines on changing standards of CKD care.
American College of Cardiology
OCTOBER 31, 2024
What is the impact of catheter ablation on the short- and mid-term survival of patients admitted for electrical storm?
Medical Xpress - Cardiology
OCTOBER 31, 2024
In a recent study, the regulatory role of the long noncoding RNA (lncRNA) Gm20257 in pathological cardiac hypertrophy has been elucidated, offering new insights into potential therapeutic targets. Pathological cardiac hypertrophy, a condition characterized by an abnormal increase in heart muscle size, can lead to heart failure if left unchecked.
American College of Cardiology
OCTOBER 31, 2024
The goal of the CLASP IID trial was to assess the safety and efficacy of the PASCAL system compared with the MitraClip among patients with degenerative mitral regurgitation (MR) who were at prohibitive surgical risk.
Becker's Hospital Review - Cardiology
OCTOBER 31, 2024
The BiVACOR Total Artificial Heart is included on the 'The Best Inventions of 2024' list published Oct. 30 in Time.
HCPLive
OCTOBER 31, 2024
In part 2 of this 5-part series, Lerma and Lala-Trindade discuss the key differences in MoA for nsMRA and MRAs.
Journal of Cardiothoracic Surgery
OCTOBER 31, 2024
In our study, we aim to explore the structural differences between the aortic root and the pulmonary artery to better understand the process of pulmonary autograft dilatation during the Ross procedure.
HeartRhythm
OCTOBER 31, 2024
Ventricular arrhythmias commonly originate from the ventricular outflow tract (VOT). It remains unexplored whether pulsed-field ablation (PFA) can create durable lesions safely at the VOT.
Expert insights. Personalized for you.
124 
Let's personalize your content